Terrence Flynn
Analyst, Morgan Stanley
Replay available
Johnson & Johnson (JNJ) Q4 2025 Earnings Call
Johnson & Johnson (NYSE: JNJ) Q4 2025 earnings conference call, held 2026-01-21. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Joe Wolk
Executive Vice President and Chief Financial Officer
Larry Beagleson
Analyst, Wells Fargo Securities
Vamo Devan
Analyst, Prudenheim Security
Darren Snellgrove
Vice President, Business Results
Danielle Antofi
Analyst, UBS
Alexandria Hammond
Analyst, Wolfe Research
Joanne Wunsch
Analyst, Citibank
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Johnson & Johnson.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.518 Good morning and welcome to Johnson & Johnson's fourth quarter 2025 earnings conference 00:00:04.518 -- 00:00:08.964 call. All participants will be in a listening mode until the question and answer session 00:00:08.964 -- 00:00:10.627 of the conference. 00:00:10.627 -- 00:00:15.494 This call is being recorded. If anyone has any objections, you may disconnect at this 00:00:15.494 -- 00:00:20.261 time. If you experience technical difficulties during the conference, you may press star 00:00:20.261 -- 00:00:24.928 zero to reach the operator. I will now turn the conference call over to Johnson & Johnson. 00:00:24.928 -- 00:00:27.188 You may begin. 00:00:27.419 -- 00:00:31.885 Hello, everyone. This is Darren Snellgrove, Vice President 00:00:37.483 -- 00:00:42.014 of Business Results for the fourth quarter and full year 2025 00:00:42.014 -- 00:00:45.417 and our financial outlook for 2020. 00:01:22.651 -- 00:01:27.338 certainties that may cause the company's actual results to differ materially from those 00:01:27.338 -- 00:01:28.660 projected. 00:01:28.660 -- 00:01:31.361 The description of these, 00:01:34.308 -- 00:01:37.133 including our 2024 Form 10-K, 00:01:37.133 -- 00:01:40.174 which is available at investor.jnj.com 00:01:40.518 -- 00:01:42.850 and on the SEC's website. 00:01:42.850 -- 00:01:47.275 Additionally, several of the products and compounds discussed today are being developed 00:01:47.275 -- 00:01:51.681 in collaboration with strategic partners or licensed from other companies. 00:01:51.681 -- 00:01:55.142 This slide acknowledges those relationships. 00:01:55.345 -- 00:02:00.611 Moving to today's agenda, Joaquin Duarte, our chairman and CEO, will discuss our business 00:02:00.611 -- 00:02:06.458 performance and growth driver...